Concepedia

Mark Sklar

MS

Statistics

Publications

8

Citations

685

H-Index

8

Active since

1988

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Physicians Committee for Responsible Medicine

Mark Sklar is an author at National Cancer Institute specializing in insulin-like growth factors, life sciences, and endocrinology.

Publications per year

1988–2024

8

Publications

8

Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.

G D Blickenstaff, Mark Sklar, Cheryl L. Thomas et al. · Journal of Biological Chemistry · 1988 · 190 citations · Full text

, , +12

Toward Improved Management of NIDDM: A Randomized, Controlled, Pilot Intervention Using a Lowfat, Vegetarian Diet

A Nicholson, Mark Sklar, Neal D. Barnard et al. · Preventive Medicine · 1999 · 171 citations

, , +16

Developmental Expression of the Tissue Insulin-like Growth Factor II/Mannose 6-Phosphate Receptor in the Rat

Mark Sklar, Cheryl L. Thomas, S. Peter Nissley · Journal of Biological Chemistry · 1989 · 103 citations · Full text

, , +15

Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II/mannose 6-phosphate receptor

Cheryl L. Thomas, Lawrence A. Greenstein, L Lee et al. · Journal of Biological Chemistry · 1989 · 94 citations · Full text

, , +15

β‐Galactosidase decreases the binding affinity of the insulin‐like‐growth‐factor‐II/mannose‐6‐phosphate receptor for insulin‐like‐growth‐factor II

Cheryl L. Thomas, Mark Sklar, S. Peter Nissley · European Journal of Biochemistry · 1990 · 50 citations · Full text

, , +12

1–5 of 8